These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29606545)
1. Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence. Morrison AP Schizophr Res; 2019 Jan; 203():94-98. PubMed ID: 29606545 [TBL] [Abstract][Full Text] [Related]
3. Brief cognitive behavioural therapy for hallucinations: can it help people who decide not to take antipsychotic medication? A case report. Hutton P; Morrison AP; Taylor H Behav Cogn Psychother; 2012 Jan; 40(1):111-6. PubMed ID: 21740604 [TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
5. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series. Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197 [TBL] [Abstract][Full Text] [Related]
6. Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review. Cooper RE; Laxhman N; Crellin N; Moncrieff J; Priebe S Schizophr Res; 2020 Nov; 225():15-30. PubMed ID: 31126806 [TBL] [Abstract][Full Text] [Related]
7. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants. O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100 [TBL] [Abstract][Full Text] [Related]
8. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia. Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804 [TBL] [Abstract][Full Text] [Related]
9. The treatment of hallucinations in schizophrenia spectrum disorders. Sommer IE; Slotema CW; Daskalakis ZJ; Derks EM; Blom JD; van der Gaag M Schizophr Bull; 2012 Jun; 38(4):704-14. PubMed ID: 22368234 [TBL] [Abstract][Full Text] [Related]
10. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270 [TBL] [Abstract][Full Text] [Related]
11. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
12. What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis. Gray R; Deane K J Psychiatr Ment Health Nurs; 2016 Mar; 23(2):108-15. PubMed ID: 26914866 [TBL] [Abstract][Full Text] [Related]
13. Cognitive behavioral therapy for schizophrenia. Rathod S; Phiri P; Kingdon D Psychiatr Clin North Am; 2010 Sep; 33(3):527-36. PubMed ID: 20599131 [TBL] [Abstract][Full Text] [Related]
14. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial. Morrison AP; Hutton P; Wardle M; Spencer H; Barratt S; Brabban A; Callcott P; Christodoulides T; Dudley R; French P; Lumley V; Tai SJ; Turkington D Psychol Med; 2012 May; 42(5):1049-56. PubMed ID: 21914252 [TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
17. Cognitive behaviour therapy for schizophrenia. Jones C; Cormac I; Mota J; Campbell C Cochrane Database Syst Rev; 2000; (2):CD000524. PubMed ID: 10796390 [TBL] [Abstract][Full Text] [Related]
18. [Update on current care guidelines: schizophrenia]. Salokangas RK; Tuominen L; Koponen H; Laukkala T; Oksanen J; Pirkola S; Saxen U Duodecim; 2013; 129(8):846-7. PubMed ID: 23720952 [TBL] [Abstract][Full Text] [Related]
19. Delivery of cognitive-behaviour therapy for psychosis: a service user preference trial. Haddock G; Berry K; Davies G; Dunn G; Harris K; Hartley S; Holland F; Kelly J; Law H; Morrison AP; Mulligan J; Neil ST; Pitt L; Rivers Z; Taylor CDJ; Wass R; Welford M; Woodward S; Barrowclough C J Ment Health; 2018 Aug; 27(4):336-344. PubMed ID: 29271276 [TBL] [Abstract][Full Text] [Related]